MediWound Ltd. (MDWD) vs Organogenesis Holdings Inc. (ORGO)
A side-by-side comparison of MediWound Ltd. and Organogenesis Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MDWD
MediWound Ltd.
$13.23HealthcareDelayed quote: Oct 6, 2026, 12:44 PM EDT
ORGO
Organogenesis Holdings Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 12:48 PM EDT
Total return — MDWD vs ORGO
growth of $100 · dividends reinvested · last 10yMDWD -62.5% (-9.3%/yr)ORGO -86.8% (-18.3%/yr)MDWD compounded faster over this window
MDWD ORGO
MDWD vs ORGO: by the numbers
- •ORGO is the larger company ($171M vs $170M market cap).
- •Both run net losses; ORGO's is the smaller (-19.76% vs -170.10% net margin).
- •ORGO grew revenue faster over the past five years (1.05% vs -13.99% CAGR).
Metrics side by side
Valuation
| Metric | MDWD | ORGO |
|---|---|---|
| P/S ratio | 14.32 | 0.37 |
| P/B ratio | 4.77 | 1.15 |
| EV / EBITDA | N/A | 215.48 |
| FCF yield | N/A | 12.18% |
Profitability
| Metric | MDWD | ORGO |
|---|---|---|
| Gross margin | 15.46% | 67.59% |
| Operating margin | -149.06% | 9.92% |
| Net margin | -170.10% | -19.76% |
| ROE | -56.61% | -31.32% |
| ROIC | -58.55% | -8.34% |
Growth (annualized)
| Metric | MDWD | ORGO |
|---|---|---|
| Revenue CAGR (5Y) | -13.99% | 1.05% |
| FCF CAGR (5Y) | N/A | -5.54% |
| Total return CAGR (5Y) | -9.04% | -37.41% |
Frequently asked
- Which has grown faster, MDWD or ORGO?
- Over the past five years, ORGO grew revenue faster — MDWD at a -13.99% CAGR versus ORGO at 1.05%.
- How have MDWD and ORGO total returns compared?
- Over the past 5 years, MDWD delivered -9.04% and ORGO delivered -37.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
MediWound ROEOrganogenesis ROEMediWound operating marginOrganogenesis operating marginMediWound revenue growthOrganogenesis revenue growthMediWound free cash flowOrganogenesis free cash flow
MediWound & Organogenesis appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.